Hiroshi Ida Selected Research

Hiroshi Ida Research Topics

Disease

26	Neoplasms (Cancer) 02/2024 - 03/2004
22	Hepatocellular Carcinoma (Hepatoma) 02/2024 - 01/2010
6	Stomach Neoplasms (Stomach Cancer) 07/2009 - 09/2005
4	Liver Neoplasms (Liver Cancer) 10/2022 - 10/2015
3	Chronic Hepatitis B 09/2022 - 01/2018
3	Chronic Hepatitis C 01/2017 - 10/2015
3	Liver Diseases (Liver Disease) 01/2017 - 11/2008
3	Infections 01/2017 - 01/2010
3	Carcinogenesis 01/2017 - 11/2006
3	Ascites 01/2016 - 01/2010
2	Neoplasm Metastasis (Metastasis) 02/2017 - 01/2016
2	Autoimmune Pancreatitis 01/2017 - 11/2008
2	Liver Cirrhosis (Hepatic Cirrhosis) 01/2017 - 01/2016
2	Inflammation (Inflammations) 01/2017 - 01/2017
2	Biliary Tract Neoplasms (Biliary Tract Cancer) 04/2011 - 06/2007
1	Cholangiocarcinoma 04/2023
1	Jaundice (Icterus) 10/2022
1	Cholangitis 10/2022
1	Pathologic Constriction (Stenosis) 10/2022
1	Diverticulum 10/2022
1	Lung Neoplasms (Lung Cancer) 10/2022
1	Erythropoietic Protoporphyria 01/2018
1	Hepatitis 01/2018
1	Disease Progression 01/2018
1	Autoimmune Hepatitis 01/2017
1	Hepatitis C 01/2017
1	Fibrosis (Cirrhosis) 01/2017
1	Pancreatitis 01/2017
1	Virus Diseases (Viral Diseases) 01/2017
1	Liver Cell Adenoma (Hepatocellular Adenoma) 01/2017
1	Cysts 01/2016

Drug/Important Bio-Agent (IBA)

8	Immune Checkpoint InhibitorsIBA 02/2024 - 08/2020
6	InterferonsIBA 07/2021 - 10/2015
4	Antiviral Agents (Antivirals)IBA 10/2019 - 01/2017
4	Biomarkers (Surrogate Marker)IBA 02/2017 - 11/2007
4	Transforming Growth Factor beta (TGF-beta)IBA 06/2007 - 03/2004
3	Programmed Cell Death 1 ReceptorIBA 02/2024 - 10/2020
3	CateninsIBA 04/2023 - 07/2021
3	lenvatinibIBA 10/2020 - 07/2019
3	LigandsIBA 10/2020 - 04/2010
3	Transcription Factors (Transcription Factor)IBA 12/2007 - 03/2004
2	B7-H1 AntigenIBA 02/2024 - 07/2021
2	atezolizumabIBA 09/2023 - 04/2023
2	Bevacizumab (Avastin)FDA Link 09/2023 - 04/2023
2	EnzymesIBA 10/2022 - 01/2018
2	Proteins (Proteins, Gene)FDA Link 08/2020 - 09/2005
2	entecavir FDA Link 10/2019 - 01/2018
2	AlbuminsIBA 07/2019 - 01/2016
2	BilirubinIBA 07/2019 - 01/2018
2	thiamine triphosphorate (TTP)IBA 06/2017 - 01/2017
2	MicroRNAs (MicroRNA)IBA 02/2017 - 09/2015
2	Sorafenib (BAY 43-9006)FDA Link 02/2017 - 10/2015
2	SofosbuvirIBA 01/2017 - 01/2016
2	CytokinesIBA 01/2017 - 08/2010
2	daclatasvirIBA 01/2017 - 01/2016
2	asunaprevirIBA 01/2017 - 01/2016
2	Serum AlbuminIBA 01/2017 - 01/2016
2	Ribavirin (Virazole)FDA LinkGeneric 01/2016 - 10/2015
2	Tolvaptan FDA Link 01/2016 - 01/2016
2	Furosemide (Lasix)FDA LinkGeneric 01/2016 - 01/2016
2	Histone Deacetylase InhibitorsIBA 04/2011 - 04/2007
2	Vorinostat FDA Link 04/2011 - 04/2007
1	AntigensIBA 04/2023
1	Immune Checkpoint ProteinsIBA 04/2023
1	Prothrombin (Factor II)IBA 10/2022
1	alpha-Fetoproteins (alpha-Fetoprotein)IBA 10/2022
1	Prednisolone (Predate)FDA LinkGeneric 10/2022
1	PlasticsIBA 10/2022
1	pembrolizumabIBA 10/2022
1	A-factor (Streptomyces)IBA 10/2022
1	gadolinium ethoxybenzyl DTPA FDA Link 11/2021
1	diethylenetriamineIBA 11/2021
1	GadoliniumIBA 11/2021
1	Ligases (Synthetase)IBA 07/2021
1	Glutamic Acid (Glutamate)FDA Link 07/2021
1	Fetal Proteins (Fetoprotein)IBA 07/2021
1	Phosphatidylinositols (Phosphatidylinositol)IBA 08/2020
1	Keratin-19 (Keratin 19)IBA 08/2020
1	tenofovir alafenamideIBA 10/2019
1	Tenofovir (Viread)FDA Link 01/2018
1	Ferrochelatase (Heme Synthetase)IBA 01/2018
1	Lamivudine (Epivir)FDA Link 01/2018
1	Surface Antigens (Surface Antigen)IBA 01/2018
1	locked nucleic acidIBA 02/2017
1	acarboxyprothrombin (PIVKA)IBA 02/2017
1	Poly I-CIBA 01/2017
1	Interleukin-33IBA 01/2017
1	ledipasvirIBA 01/2017
1	DiureticsIBA 01/2016
1	Spironolactone (Aldactone)FDA LinkGeneric 01/2016
1	Zonula Occludens-1 ProteinIBA 01/2016

Therapy/Procedure

15	Therapeutics 09/2023 - 01/2015
4	Radiofrequency Ablation 10/2021 - 01/2016
2	Immunotherapy 02/2024 - 04/2023
2	Aftercare (After-Treatment) 10/2022 - 07/2009
2	Hepatectomy 01/2017 - 01/2016
1	Stents 10/2022
1	Time-to-Treatment 07/2019
1	Liver Transplantation 09/2018
1	Drug Therapy (Chemotherapy) 09/2018